Synergy Pharmaceuticals Inc. | Key People and Executives
Gary S. Jacob
Executive Chairman
Troy Hamilton
Chief Executive Officer & Director
Melvin K. Spigelman
Lead Independent Director
Timothy Sean Callahan
Independent Director
Thomas H. Adams
Independent Director
Alan F. Joslyn
Independent Director
John P. Brancaccio
Independent Director
Gary S. Jacob
Executive Chairman
Troy Hamilton
Chief Executive Officer & Director
Gary G. Gemignani
Secretary, CFO, Principal Accounting Officer & EVP
Patrick H. Griffin
Chief Medical Officer & Executive Vice President
Leslie M. Magnus
Senior Vice President-Medical Affairs
Daniel Dunham
Chief Compliance Officer & Senior Vice President
Stephen Comiskey
Vice President-Product Development
Marino Garcia
Chief Strategy Officer & Executive Vice President
Pam Cebulski
Senior Vice President-Marketing
Marianne Jackson
Senior Vice President-Sales & Market Access
Gem Hopkins
Vice President-Investor Relations
Melvin K. Spigelman
Lead Independent Director
Timothy Sean Callahan
Independent Director
Thomas H. Adams
Independent Director
Alan F. Joslyn
Independent Director
John P. Brancaccio
Independent Director
| Address |
420 Lexington Avenue
New York New York 10170
United States
|
|
Employees
|
- |
| Website |
http://www.synergypharma.com |
| Updated |
09/14/2018 |
| Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY. |
